Get the Stockscreener App
6.01
3.98%
+0.23
Biote Corp stock is currently priced at $6.01, with a 24-hour trading volume of 44,310.
It has seen a +3.98% increased in the last 24 hours and a +1.86% rose in the past month.
The chart indicates a potential bullish trend, as the stock is above the $5.70 pivot point. If it approaches the $6.14 resistance level, significant changes may occur.
Previous Close:
$5.78
Open:
$5.86
24h Volume:
44,310
Market Cap:
$217.65M
Revenue:
$185.36M
Net Income/Loss:
$3.32M
P/E Ratio:
-
EPS:
-
Net Cash Flow:
$24.17M
1W Performance:
+8.88%
1M Performance:
+1.86%
6M Performance:
-35.80%
1Y Performance:
+11.17%
1D Range:
$5.71
$6.09
52W Range:
$3.6538
$7.50
Biote Corp Stock (BTMD) Company Profile
Name
Biote Corp
Sector
Industry
Phone
972-486-9346
Address
1875 W. WALNUT HILL LN #100, IRVING
Biote Corp Stock (BTMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-24-22 | Initiated | Cowen | Outperform |
| Jun-23-22 | Initiated | ROTH Capital | Buy |
Biote Corp Stock (BTMD) Latest News
Analysts Estimate QuidelOrtho (QDEL) to Report a Decline in Earnings: What to Look Out for
Zacks Investment Research
Aurora Cannabis (ACB) Moves 46.0% Higher: Will This Strength Last?
Zacks Investment Research
Earnings Preview: biote Corp. (BTMD) Q1 Earnings Expected to Decline
Zacks Investment Research
Analysts Estimate biote Corp. (BTMD) to Report a Decline in Earnings: What to Look Out for
Zacks Investment Research
ICU Medical (ICUI) Q4 Earnings and Revenues Surpass Estimates
Zacks Investment Research
Biote Corp. (BTMD) Reports Q3 Loss, Lags Revenue Estimates
Zacks Investment Research
Biote Corp Stock (BTMD) Financials Data
Biote Corp (BTMD) Revenue 2024
BTMD reported a revenue (TTM) of $185.36 million for the quarter ending December 31, 2023, a +12.37% rise year-over-year.
Biote Corp (BTMD) Net Income 2024
BTMD net income (TTM) was $3.32 million for the quarter ending December 31, 2023, a -60.43% decrease year-over-year.
Biote Corp (BTMD) Cash Flow 2024
BTMD recorded a free cash flow (TTM) of $24.17 million for the quarter ending December 31, 2023, a +319.83% increase year-over-year.
Biote Corp (BTMD) Earnings per Share 2024
BTMD earnings per share (TTM) was -$0.08 for the quarter ending December 31, 2023, a -107.43% decline year-over-year.
About Biote Corp
Biote Corp is engaged in bioidentical hormone replacement optimization platform and complementary nutraceutical business. The company offers end-to-end platform that provides practitioners with medical education, training and certification, practice management software, and digital and point-of-care marketing support.
0.27%
0.29%
Cap:
|
Volume (24h):